Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells.
The goal of this research was to evaluate the roles of calpains and their interactions with the proteasome and the lysosome in degradation of individual sarcomeric and cytoskeletal proteins in cultured muscle cells. Rat L8-CID muscle cells, in which we expressed a transgene calpain inhibitor (CID), were used in the study. L8-CID cells were grown as myotubes after which the relative roles of calpain, proteasome and lysosome in total protein degradation were assessed during a period of serum withdrawal. Following this, the roles of proteases in degrading cytoskeletal proteins (desmin, dystrophin and filamin) and of sarcomeric proteins (alpha-actinin and tropomyosin) were assessed. Total protein degradation was assessed by release of radioactive tyrosine from pre-labeled myotubes in the presence and absence of protease inhibitors. Effects of protease inhibitors on concentrations of individual sarcomeric and cytoskeletal proteins were assessed by Western blotting. Inhibition of calpains, proteasome and lysosome caused 20, 62 and 40% reductions in total protein degradation (P<0.05), respectively. Therefore, these three systems account for the bulk of degradation in cultured muscle cells. Two cytoskeletal proteins were highly-sensitive to inhibition of their degradation. Specifically, desmin and dystrophin concentrations increased markedly when calpain, proteasome and lysosome activities were inhibited. Conversely, sarcomeric proteins (alpha-actinin and tropomyosin) and filamin were relatively insensitive to the addition of protease inhibitors to culture media. These data demonstrate that proteolytic systems work in tandem to degrade cytoskeletal and sarcomeric protein complexes and that the cytoskeleton is more sensitive to inhibition of degradation than the sarcomere. Mechanisms, which bring about changes in the activities of the proteases, which mediate muscle protein degradation are not known and represent the next frontier of understanding needed in muscle wasting diseases and in muscle growth biology.
Purintrapiban
Juntipa
J
Department of Animal Sciences, Oregon State University, Corvallis, OR 97331-6702, USA.
Wang
Mei-chuan
MC
Forsberg
Neil E
NE
D000185:Actinin / Q000378:metabolism; D000818:Animals; D002154:Calpain / Q000378:metabolism*; D002478:Cells, Cultured; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D006868:Hydrolysis / Q000187:drug effects; D007553:Isotope Labeling; D008247:Lysosomes / Q000378:metabolism*; D009097:Multienzyme Complexes / Q000378:metabolism*; D032342:Muscle Cells / Q000201:enzymology*; D018485:Muscle Fibers, Skeletal / Q000201:enzymology; D011480:Protease Inhibitors / Q000494:pharmacology; D046988:Proteasome Endopeptidase Complex; D051381:Rats; D012518:Sarcomeres / Q000378:metabolism; D014335:Tropomyosin / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
D003598:Cytoskeletal Proteins; D009097:Multienzyme Complexes; D011480:Protease Inhibitors; D014335:Tropomyosin; D000185:Actinin; D014443:Tyrosine; D002154:Calpain; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex